149 related articles for article (PubMed ID: 9869567)
1. Therapeutic effect of clarithromycin on a transplanted tumor in rats.
Sassa K; Mizushima Y; Fujishita T; Oosaki R; Kobayashi M
Antimicrob Agents Chemother; 1999 Jan; 43(1):67-72. PubMed ID: 9869567
[TBL] [Abstract][Full Text] [Related]
2. Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.
Sassa K; Mizushima Y; Kobayashi M
Antimicrob Agents Chemother; 1999 Nov; 43(11):2787-9. PubMed ID: 10543765
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a new synthetic lipid A analog (ONO-4007) on a tumor implanted at different sites in rats.
Mizushima Y; Sassa K; Fujishita T; Oosaki R; Kobayashi M
J Immunother; 1999 Sep; 22(5):401-6. PubMed ID: 10546155
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma.
Badgwell BD; Valentino DJ; Jeffes EB; Dieffenbach K; Dulkanchainun SB; Yamamoto RS; Granger GA; Jakowatz JG; Carson WE
Cancer Immunol Immunother; 2003 Jan; 52(1):10-6. PubMed ID: 12536235
[TBL] [Abstract][Full Text] [Related]
6. A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells.
Kuramitsu Y; Nishibe M; Ohiro Y; Matsushita K; Yuan L; Obara M; Kobayashi M; Hosokawa M
Anticancer Drugs; 1997 Jun; 8(5):500-8. PubMed ID: 9215614
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
Welch DR; Fabra A; Nakajima M
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7678-82. PubMed ID: 2217201
[TBL] [Abstract][Full Text] [Related]
9. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
10. Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor.
Hoon DS; Ramshaw IA
Cancer Immunol Immunother; 1985; 20(2):175-8. PubMed ID: 3849980
[TBL] [Abstract][Full Text] [Related]
11. Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
Mizushima Y; Sassa K; Hamazaki T; Fujishita T; Oosaki R; Kobayashi M
Br J Cancer; 1998 Oct; 78(8):1030-4. PubMed ID: 9792146
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma.
Wang F; Elliott RL; Head JF
Anticancer Res; 1999; 19(1A):445-50. PubMed ID: 10226580
[TBL] [Abstract][Full Text] [Related]
13. Rat adenocarcinoma 13762 expresses tumor rejection antigens but tumor-bearing animals exhibit tumor-specific immunosuppression.
Frey AB; Appleman LJ
Clin Immunol Immunopathol; 1993 Nov; 69(2):223-33. PubMed ID: 8403560
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta production and induction of cellular responses in 13762NF rat mammary adenocarcinoma cell clones.
Kaufmann AM; Stoeck M; Schirrmacher V; Lichtner RB
Invasion Metastasis; 1993; 13(5):244-52. PubMed ID: 7960577
[TBL] [Abstract][Full Text] [Related]
15. Correlation of TGF-beta 1 expression with medroxyprogesterone acetate responsiveness in mouse mammary adenocarcinomas.
Elizalde PV; Guerra FK; Gravano M; Lanari C; Lippman ME; Charreau EH; Lupu R
Cancer Invest; 1995; 13(2):173-80. PubMed ID: 7874571
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer.
Hamada K; Mikasa K; Yunou Y; Kurioka T; Majima T; Narita N; Kita E
Chemotherapy; 2000; 46(1):49-61. PubMed ID: 10601798
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
[TBL] [Abstract][Full Text] [Related]
18. Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.
McGary CT; Miele ME; Welch DR
Am J Pathol; 1995 Dec; 147(6):1668-81. PubMed ID: 7495292
[TBL] [Abstract][Full Text] [Related]
19. Oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza A virus.
Takahashi E; Kataoka K; Indalao IL; Konoha K; Fujii K; Chida J; Mizuno D; Fujihashi K; Kido H
J Virol; 2012 Oct; 86(20):10924-34. PubMed ID: 22896605
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma.
Kakeji Y; Maehara Y; Ikebe M; Teicher BA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1115-23. PubMed ID: 9169821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
